SEI Investments’s Beam Therapeutics BEAM Stock Holding History

SEI Investments’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$273K	Sell	11,451 -16	-0.1%	-$444	﹤0.01%	2856
2025 Q4	$318K	Buy	11,467 +16	+0.1%	+$408	﹤0.01%	2710
2025 Q3	$278K	Buy	+11,451	New	+$228K	﹤0.01%	2495
2023 Q3	–	Sell	-7,142	Closed	-$228K	–	2628
2023 Q2	$228K	Buy	+7,142	New	+$232K	﹤0.01%	2436
2023 Q1	–	Sell	-5,693	Closed	-$223K	–	2688
2022 Q4	$223K	Sell	5,693 -3,536	-38%	-$158K	﹤0.01%	2312
2022 Q3	$440K	Buy	+9,229	New	+$526K	﹤0.01%	2145
2021 Q3	–	Sell	-1,740	Closed	-$224K	–	2557
2021 Q2	$224K	Sell	1,740 -8,679	-83%	-$692K	﹤0.01%	2420
2021 Q1	$851K	Hold	10,419	–	–	﹤0.01%	1820
2020 Q4	$851K	Buy	+10,419	New	+$512K	﹤0.01%	1758

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SEI Investments's BEAM Position: Q1 2026 in Review

SEI Investments reduced its Beam Therapeutics (BEAM) stake by 0.14% in Q1 2026, selling an estimated $444 and leaving 11,451 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

SEI Investments first reported a position in BEAM in Q4 2020 and has held it in 9 quarters since. The position peaked at $851K in Q1 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

SEI Investments held 11,451 shares of Beam Therapeutics worth $273K as of Q1 2026.
SEI Investments sold 16 Beam Therapeutics shares in Q1 2026, an estimated $444.
Beam Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2856 holding.
SEI Investments first reported a position in Beam Therapeutics in Q4 2020 and has held it in 9 quarters since.
SEI Investments's Beam Therapeutics position peaked at $851K in Q1 2021.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.